Page last updated: 2024-10-17

aminocaproic acid and Stomach Neoplasms

aminocaproic acid has been researched along with Stomach Neoplasms in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Stomach Neoplasms: Tumors or cancer of the STOMACH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Simon, AG1
Lyu, SI1
Laible, M1
Wöll, S1
Türeci, Ö1
Şahin, U1
Alakus, H1
Fahrig, L1
Zander, T1
Buettner, R1
Bruns, CJ1
Schroeder, W1
Gebauer, F1
Quaas, A1

Other Studies

1 other study available for aminocaproic acid and Stomach Neoplasms

ArticleYear
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
    Journal of translational medicine, 2023, 08-17, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Aminocaproic Acid; Antibodies; Claudins; Humans; Stomach Neoplasms; Tight Junction P

2023